The FDA has expanded the approval for Pluvicto (lutetium Lu 177 vipivotide tetraxetan) to include patients with PSMA-positive mCRPC who have been treated with ARPI therapy and can delay chemotherapy.

Some patients with locally advanced esophageal cancer may be able to safely forgo esophagectomy after CRT, data suggest.

Patients with metastatic NSCLC may benefit from continuing on pembrolizumab-based treatment after progressing on that treatment.

(HealthDay News) — Five leaders at the US Centers for Disease Control and Prevention (CDC) stepped down last week, according to The Associated Press, which confirmed the departures through 2 anonymous ...

The federal government is clawing back $11.4 billion in COVID-19 funding, a move that could affect local and state public health efforts across the US.

Childhood cancer survivors “may experience considerable accelerated aging throughout their lifespan,” the researchers wrote.

The Senate has confirmed Dr Jay Bhattacharya as the new director of the NIH and Dr Marty Makary as the new commissioner of the FDA.

Patients with MSI-H mCRC had a higher probability of survival with first-line ICI therapy than with chemotherapy, but second-line or later ICIs did not confer the same benefit.

The FDA has approved Gozellix (kit for the preparation of gallium Ga 68 gozetotide injection) for use in patients with prostate cancer.

The FDA has approved Cabometyx (cabozantinib) for previously treated, unresectable, locally advanced or metastatic, well-differentiated neuroendocrine tumors.

Americans living in rural communities could see their access to health care diminish if Congress changes eligibility for Medicaid or significantly reduces funding.

(HealthDay News) — Grants from the National Institutes of Health (NIH) that were funding research on LGBTQ+ health have been canceled by the US government, alarming scientists who say the move will ...